Experimental Drug Breaks Record For Weight Loss in Latest Clinical Trial Results

Null

An experimental drug being clinically investigated for its effects on body weight in obese and overweight people has delivered record-breaking weight loss for participants in the trial – on par with surgical options, the company behind the drug suggests. Tirzepatide, developed by American pharmaceutical company Eli Lilly and Company (Lilly), is a once-weekly injection that promotes weight loss ...

Read Complete Article

Post a Comment

Previous Post Next Post